Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
“Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma,” CURE; ...
Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...
Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Shots to prevent respiratory syncytial virus recommended only for high-risk babies even as experts hail jabs’ success ...
Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...
The educational campaign will focus on teaching the American public about antibodies and preventing infectious diseaseThe collaboration will ...
After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...
Modern medical breakthroughs save lives in ways that feel miraculous, showing how faith and science can work together as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results